Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   juvenile myelomonocytic leukemia
  

Disease ID 269
Disease juvenile myelomonocytic leukemia
Definition
A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.
Synonym
jcml
jcml - juvenile chronic myeloid leukaemia
jcml - juvenile chronic myeloid leukemia
jmml
juvenile chronic myelogenous leukemia
juvenile chronic myeloid leukaemia
juvenile chronic myeloid leukemia
juvenile chronic myeloid leukemia (disorder)
juvenile chronic myelomonocytic leukaemia
juvenile chronic myelomonocytic leukemia
juvenile myelomonocytic leukaemia
juvenile myelomonocytic leukemia (disorder)
juvenile myelomonocytic leukemia (jmml)
juvenile myelomonocytic leukemia (morphologic abnormality)
juvenile myelomonocytic leukemias
leukemia, juvenile myelomonocytic
leukemia, myelomonocytic, juvenile
leukemia, myelomonocytic, juvenile [disease/finding]
myelomonocytic leukemia, juvenile
myelomonocytic leukemias, juvenile
Orphanet
OMIM
DOID
UMLS
C0349639
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:2)
C0028326  |  noonan syndrome  |  3
C0042769  |  virus infection  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:19)
2624  |  GATA2  |  CTD_human
861  |  RUNX1  |  CTD_human
3845  |  KRAS  |  CLINVAR;CTD_human;ORPHANET
5781  |  PTPN11  |  CLINVAR;CTD_human;ORPHANET;UNIPROT
26040  |  SETBP1  |  CTD_human;UNIPROT
4893  |  NRAS  |  CLINVAR;CTD_human;ORPHANET;UNIPROT
4763  |  NF1  |  CLINVAR;CTD_human;ORPHANET
1788  |  DNMT3A  |  CTD_human
1437  |  CSF2  |  CTD_human
171023  |  ASXL1  |  CTD_human
10019  |  SH2B3  |  CTD_human
6237  |  RRAS  |  CTD_human
2146  |  EZH2  |  CTD_human
867  |  CBL  |  CLINVAR;CTD_human;ORPHANET
3718  |  JAK3  |  CTD_human
5880  |  RAC2  |  CTD_human
23092  |  ARHGAP26  |  CLINVAR;CTD_human;UNIPROT
22800  |  RRAS2  |  CTD_human
8233  |  ZRSR2  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:19)
3845  |  KRAS  |  CIPHER;CTD_human
4893  |  NRAS  |  CIPHER;CTD_human
5781  |  PTPN11  |  CIPHER;CTD_human
6237  |  RRAS  |  CTD_human
4763  |  NF1  |  CTD_human
3718  |  JAK3  |  CTD_human
171023  |  ASXL1  |  CTD_human
5880  |  RAC2  |  CTD_human
1788  |  DNMT3A  |  CTD_human
867  |  CBL  |  CTD_human
26040  |  SETBP1  |  CTD_human
23092  |  ARHGAP26  |  CTD_human
22800  |  RRAS2  |  CTD_human
2624  |  GATA2  |  CTD_human
2146  |  EZH2  |  CTD_human
8233  |  ZRSR2  |  CTD_human
1437  |  CSF2  |  CTD_human
861  |  RUNX1  |  CTD_human
10019  |  SH2B3  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:50)
25  |  ABL1  |  2.241  |  DISEASES
171023  |  ASXL1  |  1.567  |  DISEASES
23545  |  ATP6V0A2  |  2.221  |  DISEASES
53335  |  BCL11A  |  1.064  |  DISEASES
1050  |  CEBPA  |  1.051  |  DISEASES
1438  |  CSF2RA  |  3.158  |  DISEASES
8813  |  DPM1  |  3.358  |  DISEASES
2120  |  ETV6  |  1.191  |  DISEASES
2260  |  FGFR1  |  2.068  |  DISEASES
81608  |  FIP1L1  |  2.166  |  DISEASES
9846  |  GAB2  |  2.954  |  DISEASES
2624  |  GATA2  |  2.973  |  DISEASES
8833  |  GMPS  |  1.432  |  DISEASES
3563  |  IL3RA  |  1.362  |  DISEASES
3660  |  IRF2  |  1.268  |  DISEASES
3717  |  JAK2  |  2.626  |  DISEASES
3718  |  JAK3  |  1.388  |  DISEASES
7403  |  KDM6A  |  1.03  |  DISEASES
389421  |  LIN28B  |  1.199  |  DISEASES
5609  |  MAP2K7  |  2.678  |  DISEASES
4143  |  MAT1A  |  1.458  |  DISEASES
4145  |  MATK  |  1.106  |  DISEASES
4300  |  MLLT3  |  1.037  |  DISEASES
4352  |  MPL  |  1.199  |  DISEASES
4599  |  MX1  |  1.643  |  DISEASES
4763  |  NF1  |  4.941  |  DISEASES
4774  |  NFIA  |  1.776  |  DISEASES
4781  |  NFIB  |  1.276  |  DISEASES
4784  |  NFIX  |  2.016  |  DISEASES
4893  |  NRAS  |  4.757  |  DISEASES
5293  |  PIK3CD  |  2.201  |  DISEASES
10622  |  POLR3G  |  2.698  |  DISEASES
5781  |  PTPN11  |  7.73  |  DISEASES
5783  |  PTPN13  |  1.272  |  DISEASES
11122  |  PTPRT  |  1.972  |  DISEASES
5915  |  RARB  |  1.526  |  DISEASES
6016  |  RIT1  |  1.923  |  DISEASES
54809  |  SAMD9  |  2.113  |  DISEASES
219285  |  SAMD9L  |  2.589  |  DISEASES
8036  |  SHOC2  |  3.427  |  DISEASES
6494  |  SIPA1  |  2.137  |  DISEASES
116085  |  SLC22A12  |  1.064  |  DISEASES
6651  |  SON  |  2.089  |  DISEASES
6654  |  SOS1  |  2.549  |  DISEASES
6714  |  SRC  |  1.773  |  DISEASES
6731  |  SRP72  |  1.99  |  DISEASES
6427  |  SRSF2  |  1.825  |  DISEASES
6776  |  STAT5A  |  3.196  |  DISEASES
54790  |  TET2  |  3.936  |  DISEASES
7454  |  WAS  |  1.281  |  DISEASES
Locus
Symbol | Locus(Total Locus:5)
PTPN11  |  12q24.13
NF1  |  17q11.2
CBL  |  11q23.3
NRAS  |  1p13.2
KRAS  |  12p12.1
Disease ID 269
Disease juvenile myelomonocytic leukemia
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:3)
HP:0010783  |  Erythema  |  1
HP:0002664  |  Neoplasia  |  1
HP:0001974  |  Leukocytosis  |  1
Disease ID 269
Disease juvenile myelomonocytic leukemia
Manually Symptom
UMLS  | Name(Total Manually Symptoms:4)
C1963220  |  pulmonary hypertension
C0598766  |  leukemogenesis
C0042769  |  viral infections
C0024143  |  lupus nephritis
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C0598766  |  leukemogenesis  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:31)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs112445441NA3845KRASumls:C0349639CLINVARNA0.447805801NAKRAS1225245347CA,G,T
rs121434596NA4893NRASumls:C0349639CLINVARNA0.489977336NANRAS1114716123CT,G,A
rs121913237NA4893NRASumls:C0349639CLINVARNA0.489977336NANRAS1114716126CT,G,A
rs121913250NA4893NRASumls:C0349639CLINVARNA0.489977336NANRAS1114716127CT,G,A
rs121913529NA3845KRASumls:C0349639CLINVARNA0.447805801NAKRAS1225245350CT,G,A
rs121913530NA3845KRASumls:C0349639CLINVARNA0.447805801NAKRAS1225245351CT,G,A
rs121918454NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112450395CG,T
rs121918458NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112489080TA,G
rs121918460NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112450364TA,G
rs121918461NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112450362AC,G,T
rs121918462NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112450398CT
rs121918464219307665781PTPN11umls:C0349639BeFreePtpn11(E76K) mutation is the most common and most active Ptpn11 mutation found in JMML and acute leukemias.0.5822120832011PTPN1112112450406GA,C
rs121918464NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112450406GA,C
rs121918465NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112450407AC,G,T
rs121918546NA23092ARHGAP26umls:C0349639CLINVARNA0.360271442NAARHGAP265143041855AC,G
rs137854555NA4763NF1umls:C0349639CLINVARNA0.443800186NANF11731261810GA
rs267606602NA4763NF1umls:C0349639CLINVARNA0.443800186NANF11731221842AG
rs28933388127174365781PTPN11umls:C0349639UNIPROTSomatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.0.5822120832003NANANANANA
rs386626619167814783717JAK2umls:C0349639BeFreeIn addition, Bcr/Abl-negative classic myeloproliferative disorders are characterized by recurrent JAK2(V617F) mutations, whereas other mutations affecting the RAS signaling pathway molecules have been associated with juvenile myelomonocytic leukemia.0.0035386762006NANANANANA
rs38662661920955399861RUNX1umls:C0349639BeFreeMutations in TET2, RUNX1 and JAK2(V617F) are involved in myelodysplastic and/or myeloproliferative syndromes, and more specifically in CMML but were not found in JMML.0.1238101182010NANANANANA
rs3866266192095539954790TET2umls:C0349639BeFreeMutations in TET2, RUNX1 and JAK2(V617F) are involved in myelodysplastic and/or myeloproliferative syndromes, and more specifically in CMML but were not found in JMML.0.0021715352010NANANANANA
rs38790666625939664867CBLumls:C0349639BeFreeJuvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.0.3640716282015CBL11119278182AG
rs397507510NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112450361GA,C
rs397507520223151875781PTPN11umls:C0349639BeFreeOccurrence of acute lymphoblastic leukemia and juvenile myelomonocytic leukemia in a patient with Noonan syndrome carrying the germline PTPN11 mutation p.E139D.0.5822120832012PTPN1112112453279GC,T
rs397507520NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112453279GC,T
rs397507545NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112489083GA,C
rs397507548NA5781PTPN11umls:C0349639CLINVARNA0.582212083NAPTPN1112112489093AC
rs727504426NA867CBLumls:C0349639CLINVARNA0.364071628NACBL11119278508AG
rs7737549320955399861RUNX1umls:C0349639BeFreeMutations in TET2, RUNX1 and JAK2(V617F) are involved in myelodysplastic and/or myeloproliferative syndromes, and more specifically in CMML but were not found in JMML.0.1238101182010JAK2;INSL695073770GA,T
rs77375493167814783717JAK2umls:C0349639BeFreeIn addition, Bcr/Abl-negative classic myeloproliferative disorders are characterized by recurrent JAK2(V617F) mutations, whereas other mutations affecting the RAS signaling pathway molecules have been associated with juvenile myelomonocytic leukemia.0.0035386762006JAK2;INSL695073770GA,T
rs773754932095539954790TET2umls:C0349639BeFreeMutations in TET2, RUNX1 and JAK2(V617F) are involved in myelodysplastic and/or myeloproliferative syndromes, and more specifically in CMML but were not found in JMML.0.0021715352010JAK2;INSL695073770GA,T
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 269
Disease juvenile myelomonocytic leukemia
Case(Waiting for update.)